Advances in Circulating Tumor DNA Research
(2017)
Advances in Circulating Tumor DNA Research: pp.
-.
Chapter 11
Quantitative Assessment of BRAF V600 Mutant Circulating Cell‑Free Tumor DNA as a Tool For Therapeutic Monitoring in Metastatic Melanoma Patients Treated with BRAF/MEK Inhibitors